This research was performed To guage the potential with the CPPs with tumor-focusing on Attributes to provide a cytotoxic payload to HCC cells. We explored employing a CXCR4-concentrating on peptide, T22, fused with cytotoxic peptide PE24, like a novel therapeutic method for CXCR4+ HCC cells. T22 was picked out as the nanocarrier because of its eff